Status:
COMPLETED
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rheumatoid Arthritis
Osteoarthritis
Eligibility:
All Genders
18-75 years
Brief Summary
This study is being conducted to validate various biomarkers in patients with RA with varying levels of disease severity. Subjects with a diagnosis of rheumatoid arthritis (RA) will be included as con...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Diagnosis of rheumatoid or osteo-arthritis.
- Weight greater than 45kg (females) or 50kg (males) but not overweight.
- Non-smokers.
- Taking stable anti-inflammatory medication for Rheumatoid Arthritis (RA) or Osteoarthritis (OA) for at least 8 weeks.
- Exclusion criteria:
- Taking regular doses of glucocorticoid medication (greater than 5mg/day).
- Currently taking biological treatment for RA.
- Recent participation in another clinical trial.
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00242853
Start Date
October 1 2004
Last Update
October 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
London, United Kingdom, W6 8LH